{"product_id":"memorial-sloan-kettering-cancer-center-updates-in-hepatopancreatobiliary-malignancy-2025","title":"Memorial Sloan Kettering Cancer Center Updates in Hepatopancreatobiliary Malignancy 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: surgical oncologists and hepatologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1. Overview\u003c\/p\u003e\n\u003cp\u003e2. Learning Objectives\u003c\/p\u003e\n\u003cp\u003eEvaluate the role of hepatic arterial infusion (HAI) chemotherapy and systemic therapies in adjuvant and neoadjuvant settings.\u003c\/p\u003e\n\u003cp\u003eDebate surgical versus non-surgical approaches for resectable and unresectable liver metastases, including ablation and transplantation.\u003c\/p\u003e\n\u003cp\u003eAnalyze the utility of circulating tumor DNA (ctDNA) and molecular profiling in prognosis and treatment selection.\u003c\/p\u003e\n\u003cp\u003eDiscuss the integration of novel immunotherapies, vaccines, and targeted agents into HPB malignancy care.\u003c\/p\u003e\n\u003cp\u003eImplement multidisciplinary strategies for managing complex cases of early-onset colorectal cancer and pancreatic adenocarcinoma.\u003c\/p\u003e\n\u003cp\u003e3. Target Audience\u003c\/p\u003e\n\u003cp\u003eBest for surgical oncologists and hepatologists who want updates on HPB malignancies, advanced surgical techniques, and systemic therapies.\u003c\/p\u003e\n\u003cp\u003e4. Topics\u003c\/p\u003e\n\u003cp\u003eAblation vs Resection for Small Tumors\u003c\/p\u003e\n\u003cp\u003eAdvanced Endoscopy\u003c\/p\u003e\n\u003cp\u003eAdvanced PDAC\u003c\/p\u003e\n\u003cp\u003eALPPS- Is There Still a Role\u003c\/p\u003e\n\u003cp\u003eBiomarkers, ctDNA\u003c\/p\u003e\n\u003cp\u003eChanging Demographics of Colorectal Cancer- Young Onset CRC\u003c\/p\u003e\n\u003cp\u003eClinical Genomics, Screening\u003c\/p\u003e\n\u003cp\u003eCysts and Interception\u003c\/p\u003e\n\u003cp\u003eDefining Resectable Disease- Technical and Biologic Factors\u003c\/p\u003e\n\u003cp\u003eDiagnosis \u0026amp; Imaging – Panel Discussion and Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003eEmerging Role of Immunotherapy\u003c\/p\u003e\n\u003cp\u003eEpidemiology, Early Onset\u003c\/p\u003e\n\u003cp\u003eHAI Chemotherapy- Results in the Adjuvant Setting\u003c\/p\u003e\n\u003cp\u003eHAI FUDR — Updated Results and Conversion Systemic-Regional Therapy\u003c\/p\u003e\n\u003cp\u003eHistotripsy- What is the Real Benefit\u003c\/p\u003e\n\u003cp\u003eHomologous Repair Deficiency\u003c\/p\u003e\n\u003cp\u003eImaging in Metastatic Colorectal Cancer- Diagnosis and Assessing Treatment Response\u003c\/p\u003e\n\u003cp\u003eIntroduction – Panel Discussion and Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003eIs ctDNA a Helpful Prognostic Tool in Resectable Colorectal Cancer Liver Metastasis\u003c\/p\u003e\n\u003cp\u003eLiver Confined Disease- Updated Results of Resection\u003c\/p\u003e\n\u003cp\u003eLiver Resection with Extrahepatic Metastatic Disease- Yes or No\u003c\/p\u003e\n\u003cp\u003eLiver Transplantation- What is the Real Benefit\u003c\/p\u003e\n\u003cp\u003eMetastatic Disease — How Do I Treat\u003c\/p\u003e\n\u003cp\u003eMULTIDISCIPLINARY CASE PRESENTATIONS- Lesson from the Clinic\u003c\/p\u003e\n\u003cp\u003eNeoadjuvant Treatment for Pancreatic Cancer\u003c\/p\u003e\n\u003cp\u003eNovel Imaging, PET\u003c\/p\u003e\n\u003cp\u003eNovel Immunotherapies (Beyond Vaccines)\u003c\/p\u003e\n\u003cp\u003eNovel Therapeutics and Targeted Agents\u003c\/p\u003e\n\u003cp\u003eNovel Therapies \u0026amp; The Future – Panel Discussion and Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003ePathology, Genomics, Testing\u003c\/p\u003e\n\u003cp\u003eRAS Biology and Treatment\u003c\/p\u003e\n\u003cp\u003eResectable Liver Disease – Panel Discussion and Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003eResectable PDAC\u003c\/p\u003e\n\u003cp\u003eResectable, Borderline, \u0026amp; More – Panel Discussion and Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003eRobotic Technical Pearls (Liver, HAI)\u003c\/p\u003e\n\u003cp\u003eRole of Adjuvant-Neoadjuvant Systemic Therapy\u003c\/p\u003e\n\u003cp\u003eRole of EBRT\u003c\/p\u003e\n\u003cp\u003eRole of Molecular Profiling in Resectable Colorectal Cancer Liver Metastasis\u003c\/p\u003e\n\u003cp\u003eSurgical Innovation, Prehab\u003c\/p\u003e\n\u003cp\u003eSystemic Therapies – Panel Discussion and Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003eTwo-Stage Hepatic Resection\u003c\/p\u003e\n\u003cp\u003eUnresectable Liver Confined Disease – Panel Discussion and Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003eVaccines- Personalized, Off the Shelf\u003c\/p\u003e\n\u003cp\u003eY90 Radioembolization- Is There a Benefit\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405810946244,"sku":null,"price":97.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Memorial-Sloan-Kettering-Cancer-Center-Updates-in-Hepatopancreatobiliary-Malignancy-2025.jpg?v=1784216534","url":"https:\/\/medicalcoursespro.com\/products\/memorial-sloan-kettering-cancer-center-updates-in-hepatopancreatobiliary-malignancy-2025","provider":"Medicalcoursespro","version":"1.0","type":"link"}